ascendis pharma glp-1 receptor agonists weight management diabetes treatments single, dual, and triple for treating type 2 and obesity: a narrative review ascendis pharma glp-1 receptor agonist
Description
They do this by mimicking glucagon-like peptide-1 (GLP-1), a hormone made naturally in the human gut
Why the hype: Diabetes, obesity, and vascular disease are known contributors to brain aging and dementia risk
Reduce the GLP-1 dose over several weeks while simultaneously starting the alternative medication
Any real decision to change dose on an investigational drug belongs with a licensed clinician, not a troubleshooting checklist
doi: 10.1172/jci112855 9 DruckerDJPhilippeJMojsovSChickWLHabenerJF
maintenance phase of therapy
